Journal article

p53 expression by immunohistochemistry is an important determinant of survival in patients with chronic lymphocytic leukemia receiving frontline chemo-immunotherapy

Ellen J Schlette, Joan Admirand, William Wierda, Lynne Abruzzo, Katherine I Lin, Susan O'Brien, Susan Lerner, Michael J Keating, Constantine Tam

LEUKEMIA & LYMPHOMA | TAYLOR & FRANCIS LTD | Published : 2009

DOI: 10.1080/10428190903165241

Grants

Awarded by NCI NIH HHS

Citation metrics

20Web of Science

Keywords

Science & Technology
P53
Cyclophosphamide
Chromosomal-Abnormalities
Fludarabine
Hybridization
Prognostic Factors
Disease Progression
Chronic Lymphocytic Leukemia
Initial Therapy
Life Sciences & Biomedicine
Hematology
Oncology
Genetic Instability
Rituximab
Tp53 Mutations
Prognostic-Significance